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Background
Approximately 50% of the Env mass is glycan. Env glycans
shield immunogenic epitopes, and incorporation of gly-
cans provides the virus with mechanisms of immune
escape. In addition, at least one broadly neutralizing anti-
body, 2G12, has as its target a conformational glycan
epitope. To characterize the glycan antigenicity and heter-
ogeneity of expressed recombinant envelopes, we have
analyzed glycosylation profiles on clade B and clade C Env
gp140 oligomers, and characterized Env glycosylation
diversity.
Methods
Six gp140 cleavage (C) deficient and fusion (F) region
deleted oligomers were expressed either as recombinant
vaccinia virus produced proteins or as recombinant pro-
teins following transfection of 293T epithelial cells. Env
gp140CF proteins were denatured, reduced, and alkylated
prior to digestion with trypsin. The glycopeptides were
fractionated by HPLC and analyzed using mass spectrom-
etry. The spectral data was interpreted with the aid of the
web-based program GlycoPepDB.
Results
The number of glycans present did not correlate with the
number of potential glycosylation sites on each protein.
All recombinant Envs had unutilized glycosylation sites,
and Envs with more potential glycosylation sites generally
had more unutilized sites. The glycan profiles were
mapped at each glycosylation site on the six proteins.
Comparison of the profiles for conserved glycosylation
sites among the proteins showed a broad range of glycan
diversity at sites in C2, V3, C3, V4, C4, and in the gp41
membrane proximal region. This glycan diversity could
modulate exposure of potential immunogenic epitopes
and as well impact overall Env folding.
Conclusion
Glycosylation diversity was extensive on recombinant Env
oligomers, and the sites of greatest glycan diversity did not
correlate with regions of largest diversity in the gene
sequence. The technology described here provides a new
way to antigenically characterize recombinant envelope
proteins being developed as experimental HIV-1 immu-
nogens.
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